jah rapha therapeutic resources corp

53-54 65th place suite 1
maspeth, new york 11378

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 08, 2013

NYS DOS ID#
4342394

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - JAH RAPHA THERAPEUTIC RESOURCES CORP









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Marine Corps Plane Crash: The Victims
    By THE NEW YORK TIMES - Thursday Jul 13, 2017

    Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.

    Source: NYT > Home Page
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Broad Institute, Deerfield Partner to Tackle Unmet Medical Needs
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Thursday Oct 12, 2017

    Deerfield Management will provide more than $50 million for therapeutic research projects at the institute over a five-year period and is prepared to provide additional resources to advance highly promising targets....

    Source: Philanthropy News Digest (PND)
  • Could the Rockaways Survive Another Sandy?
    By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017

    Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.

    Source: NYT > Home Page
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York